Prognosis of patients with cirrhosis and hepatocellular carcinoma treated with resective surgery

被引:0
|
作者
Pittau, S [1 ]
Andorno, S [1 ]
Maduli, E [1 ]
Morelli, S [1 ]
Rigamonti, C [1 ]
Giacalone, A [1 ]
Zaccala, G [1 ]
Sartori, M [1 ]
机构
[1] 2 Med Ospedal Maggiore, Novara, Italy
关键词
D O I
10.1016/S0168-8278(01)81741-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:233 / 234
页数:2
相关论文
共 50 条
  • [1] A model to predict survival in patients with cirrhosis and hepatocellular carcinoma treated with resective surgery.
    Sartori, M
    Andorno, S
    Capelli, F
    Rigamonti, C
    Giacalone, A
    Benzoni, E
    Uzzau, A
    Pirisi, M
    HEPATOLOGY, 2004, 40 (04) : 299A - 299A
  • [2] The role of resective surgery in the treatment of hepatocellular carcinoma on cirrhosis
    Innocenti, P.
    Liddo, G.
    Raimondi, P.
    Risio, D.
    Selvaggi, F.
    GIORNALE DI CHIRURGIA, 2010, 31 (04): : 141 - 146
  • [3] Prognosis of patients with spontaneous rupture of hepatocellular carcinoma in cirrhosis
    Tarantino L.
    Sordelli I.
    Calise F.
    Ripa C.
    Perrotta M.
    Sperlongano P.
    Updates in Surgery, 2011, 63 (1) : 25 - 30
  • [4] Platelet Count and Survival of Patients With Compensated Cirrhosis and Small Hepatocellular Carcinoma Treated With Surgery
    Giannini, Edoardo G.
    Savarino, Vincenzo
    HEPATOLOGY, 2014, 59 (04) : 1649 - 1649
  • [5] Arterial chemoembolization in hepatocellular carcinoma suitable for resective surgery
    Portolani, N
    Tiberio, GAM
    Bonardelli, S
    Grazioli, L
    Matricardi, L
    Benetti, A
    Bertoloni, G
    Ronconi, M
    Giulini, SM
    HEPATO-GASTROENTEROLOGY, 1996, 43 (12) : 1566 - 1574
  • [6] The prognosis and the recurrence of RFA treated patients with hepatocellular carcinoma
    Takigawa, Atsuo
    Sakamori, Ryotaro
    Tatsumi, Tomohide
    Yakushijin, Takayuki
    Kegasawa, Tadashi
    Makino, Yuki
    Tawara, Seiichi
    Saito, Yoshinobu
    Onishi, Yoshiki
    Tanaka, Satoshi
    Furuta, Kunimaro
    Shigekawa, Minoru
    Hikita, Hayato
    Hiramatsu, Naoki
    Takehara, Tetsuo
    HEPATOLOGY, 2015, 62 : 437A - 438A
  • [7] INFLUENCE OF COEXISTING CIRRHOSIS ON LONG-TERM PROGNOSIS AFTER SURGERY IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA
    SASAKI, Y
    IMAOKA, S
    MASUTANI, S
    OHASHI, I
    ISHIKAWA, O
    KOYAMA, H
    IWANAGA, T
    SURGERY, 1992, 112 (03) : 515 - 521
  • [8] Non-resective ablation and liver transplantation in patients with cirrhosis and hepatocellular carcinoma (HCC): Safety and efficacy
    Maluf, D
    Fisher, RA
    Maroney, T
    Cotterell, A
    Fulcher, A
    Tisnado, J
    Contos, M
    Luketic, V
    Stravitz, R
    Shiffman, M
    Sterling, R
    Posner, M
    AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (03) : 312 - 317
  • [9] Changes of Cytokines in Cirrhosis Patients With Advanced Hepatocellular Carcinoma Treated by Sorafenib
    Nagai, Hidenari
    Mukozu, Takanori
    Matui, Daigo
    Ogino, Yu
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S979 - S979
  • [10] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Inghilesi, Andrea L.
    Gallori, Donatella
    Antonuzzo, Lorenzo
    Forte, Paolo
    Tomcikova, Daniela
    Arena, Umberto
    Colagrande, Stefano
    Pradella, Silvia
    Fani, Bernardo
    Gianni, Elena
    Boni, Luca
    Laffi, Giacomo
    Di Costanzo, Francesco
    Marra, Fabio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (03) : 786 - 794